Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 22 citing Yamada: Pancreatic and extrapancreatic effects of gastric inhibitory polypeptide. (0.09 sec) 

GIP receptor antagonism reverses obesity, insulin resistance, and associated …

- physiology.org
PL McClean, N Irwin, RS Cassidy, JJ Holst … - American Journal of …, 2007 - Am Physiological Soc
The gut hormone gastric inhibitory polypeptide (GIP) plays a key role in glucose homeostasis
and lipid metabolism. This study investigated the effects of administration of a stable and specific
GIP receptor antagonist, (Pro 3 )GIP, in mice previously fed a high-fat diet for 160 days to ...
Cited by 27 - Related articles - BL Direct - All 3 versions

Incretin hormone mimetics and analogues in diabetes therapeutics

- qub.ac.uk [PDF] 
BD Green, PR Flatt - Best Practice & Research Clinical Endocrinology & …, 2007 - Elsevier
The incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic
polypeptide (GIP) are physiological gut peptides with insulin-releasing and extrapancreatic glucoregulatory
actions. Incretin analogues/mimetics activate GLP-1 or GIP receptors whilst avoiding ...
Cited by 29 - Related articles - All 17 versions

Chemical gastric inhibitory polypeptide receptor antagonism protects against …


VA Gault, PL McClean, RS Cassidy, N Irwin, PR Flatt - Diabetologia, 2007 - Springer
Abstract Aims/hypothesis Gastric inhibitory polypeptide (GIP) re- ceptor antagonism with (Pro
3 )GIP improves glucose toler- ance and ameliorates insulin resistance and abnormalities of
islet structure/function in ob/ob mice. This study examined the ability of (Pro 3 )GIP to ...
Cited by 16 - Related articles - BL Direct - All 4 versions

Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid …


S Edfalk, P Steneberg, H Edlund - Diabetes, 2008 - Am Diabetes Assoc
OBJECTIVE—The G-protein–coupled receptor Gpr40 is expressed in β-cells where it contributes
to free fatty acid (FFA) enhancement of glucose-stimulated insulin secretion (1–4). However,
other sites of Gpr40 expression, including the intestine, have been suggested. The ...
Cited by 16 - Related articles - All 4 versions

Effective surgical treatment of obesity may be mediated by ablation of the lipogenic …


PR Flatt - Diabetes & Vascular Disease Research, 2007 - dvr.sagepub.com
Abstract R oux-en-Y bypass surgery is increasingly used for treatment of gross obesity due to
the general inabil- ity of lifestyle change and existing drug treatments to counter the obesity
epidemic. This common form of bariatric surgery involves bypass of the small intestine ...
Cited by 13 - Related articles - BL Direct - All 6 versions

Dorothy Hodgkin Lecture 2008 Gastric inhibitory polypeptide (GIP) revisited: a new …


PR Flatt - Diabetic Medicine, 2008 - interscience.wiley.com
There is increasing realization that gastric inhibitory polypeptide (GIP) has actions outside of
the pancreas and gastrointestinal tract. Most significant is the presence of functional GIP receptors
on adipocytes and the appreciation that GIP, secreted strongly in response to fat ...
Cited by 7 - Related articles - All 3 versions

Genetic inactivation of GIP signaling reverses aging-associated insulin resistance …


C Yamada, Y Yamada, K Tsukiyama, K Yamada, S … - … and Biophysical Research …, 2007 - Elsevier
Aging is associated with increased fat mass and decreased lean mass, which is strongly associated
with the development of insulin resistance. Gastric inhibitory polypeptide (GIP) is known to promote
efficient storage of ingested nutrients into adipose tissue; we examined aging-associated ...
Cited by 5 - Related articles - All 4 versions

Pro (3)) GIP [mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory …


PL McClean, N Irwin, K Hunter, VA Gault, … - British journal of …, 2008 - ncbi.nlm.nih.gov
BACKGROUND AND PURPOSE: Antagonism of the gastric inhibitory polypeptide (GIP) receptor
with daily injection of proline-3 gastric inhibitory polypeptide ((Pro(3))GIP) can reverse or prevent
many of the metabolic abnormalities associated with diet-induced obesity-diabetes ( ...
Cited by 5 - Related articles - All 2 versions

QTL detection on porcine chromosome 12 for fatty-acid composition and …


G Muñoz, E Alves, A Fernández, C Óvilo, C … - Animal …, 2007 - interscience.wiley.com
Refinement of previous QTL on porcine chromosome 12 for fatty-acid composition and a candidate
gene association analysis were conducted using an Iberian × Landrace cross. The concentrations
of ten fatty acids were assayed in backfat tissue from which four metabolic ratios were ...
Cited by 5 - Related articles - BL Direct - All 4 versions

Inhibition of GIP signaling modulates adiponectin levels under high-fat diet in mice


R Naitoh, K Miyawaki, N Harada, W Mizunoya, K … - … and Biophysical Research …, 2008 - Elsevier
Gastric inhibitory polypeptide (GIP) is an incretin and directly promotes fat accumulation in
adipocytes. Inhibition of GIP signaling prevents onset of obesity and increases fat oxidation in
peripheral tissues under high-fat diet (HFD), but the mechanism is unknown. In the ...
Cited by 2 - Related articles - All 2 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google